16-30 of 32
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Martha Gulati, MD, MS, FACC, FAHA
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry FeatureBreakthrough Technology Improves Concussion Assessment and Player Safety
Thomas S. Bottiglieri, DO
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Elizabeth Perkins, MD
Dawn Carter
- advertisement
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Marwan Sabbagh, MD, FAAN, CCR
Cara Leahy, DO
David Weisman, MD
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
George Grossberg, MD
Angela Sanford, MD, CMD
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk
Lauren Osborne, M.D.
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Evidence Builds for Cell-Based Influenza Vaccines
Medical Industry FeatureEvidence Builds for Cell-Based Influenza Vaccines
Jennifer Caudle, DO, FACOFP
Wendy Wright, DNP, FNP-BC, ANP-BC
Adjuvanted vs High-Dose Influenza Vaccines: A Real-World Evidence Study
Medical Industry FeatureAdjuvanted vs High-Dose Influenza Vaccines: A Real-World Evidence Study
Jennifer Caudle, DO, FACOFP
Blen Girmay, MD
- advertisement
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry FeatureImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Help Protect Your Older Patients This Flu Season: Examining Real-World Data
Medical Industry FeatureHelp Protect Your Older Patients This Flu Season: Examining Real-World Data
Charles Turck, PharmD, BCPS, BCCCP
Stephen I. Pelton, MD
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
